Patents by Inventor James Searle
James Searle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12588999Abstract: Systems and methods include a method to fuse two sections of bone. The method includes various operations such as accessing the chest cavity (e.g., by severing the sternum) and preparing the sternal edges of the two sections of bone. Sternal wires are implanted around the two sections of bone to create a cradle in a space between the two sections of bone. Cancellous bone tissue may be harvested from the patient and used to hydrate an implant before trimming the implant and/or placing the implant in the cradle. The sternal wires are tightened to compress the implant between the two sections of bone; and the ends of the sternal wires are tied together to create a sternal structure comprised of the implant tightly compressed between the two sections of bone. The sternal construct can act as a bone gasket to improve healing and fusing for the two sections of bone.Type: GrantFiled: January 13, 2022Date of Patent: March 31, 2026Assignee: THORAGENIX INNOVATIONS, INC.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Patent number: 12575933Abstract: A synthetic implant is provided that is operable to be disposed between and fuse two sections of a bone. The synthetic implant includes a synthetic material that is operable to abut against the two sections of the bone. The synthetic material is porous and/or fibrous and is operable to receive at least one cellular growth factor. The synthetic material can be combined with other synthetic materials or human bone tissue or animal bone tissue or other human or animal tissue that is suitable to act as a platform or scaffold on which new bone can grow or to cause bone to fuse together.Type: GrantFiled: April 6, 2021Date of Patent: March 17, 2026Assignee: THORAGENIX INNOVATIONS, INC.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Patent number: 12544230Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: GrantFiled: March 11, 2022Date of Patent: February 10, 2026Assignee: THORAGENIX INNOVATIONS, INC.Inventors: Frederick J. Thabet, Ravi Kanagala, James Searle
-
Publication number: 20220192832Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: ApplicationFiled: March 11, 2022Publication date: June 23, 2022Applicant: CryoHeart Laboratories, Inc.Inventors: Frederick J. Thabet, Ravi Kanagala, James Searle
-
Publication number: 20220133480Abstract: Systems and methods include a method to fuse two sections of bone. The method includes various operations such as accessing the chest cavity (e.g., by severing the sternum) and preparing the sternal edges of the two sections of bone. Sternal wires are implanted around the two sections of bone to create a cradle in a space between the two sections of bone. Cancellous bone tissue may be harvested from the patient and used to hydrate an implant before trimming the implant and/or placing the implant in the cradle. The sternal wires are tightened to compress the implant between the two sections of bone; and the ends of the sternal wires are tied together to create a sternal structure comprised of the implant tightly compressed between the two sections of bone. The sternal construct can act as a bone gasket to improve healing and fusing for the two sections of bone.Type: ApplicationFiled: January 13, 2022Publication date: May 5, 2022Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Patent number: 11253366Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: GrantFiled: October 31, 2019Date of Patent: February 22, 2022Assignee: CryoHeart Laboratories, Inc.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Patent number: 11197760Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes an inner layer and an outer layer. The outer layer at least partially surrounds the inner layer and is operable to abut against the two sections of the bone. The outer layer is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: GrantFiled: July 19, 2019Date of Patent: December 14, 2021Assignee: Cryoheart Laboratories, Inc.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Publication number: 20210220141Abstract: A synthetic implant is provided that is operable to be disposed between and fuse two sections of a bone. The synthetic implant includes a synthetic material that is operable to abut against the two sections of the bone. The synthetic material is porous and/or fibrous and is operable to receive at least one cellular growth factor. The synthetic material can be combined with other synthetic materials or human bone tissue or animal bone tissue or other human or animal tissue that is suitable to act as a platform or scaffold on which new bone can grow or to cause bone to fuse together.Type: ApplicationFiled: April 6, 2021Publication date: July 22, 2021Applicant: CryoHeart Laboratories, Inc.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Publication number: 20200060829Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: ApplicationFiled: October 31, 2019Publication date: February 27, 2020Applicant: CryoHeart Laboratories, Inc.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Publication number: 20200022814Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes an inner layer and an outer layer. The outer layer at least partially surrounds the inner layer and is operable to abut against the two sections of the bone. The outer layer is porous and/or fibrous and is operable to receive at least one cellular growth factor.Type: ApplicationFiled: July 19, 2019Publication date: January 23, 2020Applicant: CryoHeart Laboratories, Inc.Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
-
Patent number: D932403Type: GrantFiled: July 8, 2020Date of Patent: October 5, 2021Assignee: Atieva Inc.Inventors: Derek N. Jenkins, Jiyeon Kim, James Searle